Gene Query: CEP97

Dataset Description Geneva Score
Gene expression in PANC1 cells treated with Rakicidin 28.7
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 22.59
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 21.01
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 19.91
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 18.62
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 16.0
Transcriptomic analysis of LSD1 15.95
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 15.18
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 14.28
Impact of dieldrin on transcription in Jurkat T cells 12.9
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 11.87
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 11.53
IDH3a KO RNA-seq 11.2
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 11.0
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.99
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 10.48
Altering cancer transcriptomes using epigenomic inhibitors 10.48
RNAseq analysis of ESRP regulated splicing events in prostate cancer 10.42
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 10.27
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.21
The role of CFTR in islet function 10.15
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.88
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.87
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.87
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.64
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 9.58
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 9.57
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 9.51
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 9.51
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 9.47
A code of mono-phosphorylation modulates the function of RB. 9.37
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.32
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 9.31
TGF-β regulation of miRNA expression in pancreatic cancer 9.31
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 9.19
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 8.95
Zika infected neural stem cells 8.91
Transcriptome analysis of Zika infected neural stem cells 8.91
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 8.82
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 8.62
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 8.6
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 8.56
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 8.48
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 8.46
RNA sequencing of matched nephrectomy samples [RNA-seq] 8.46
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.37
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 8.22
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 8.21
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 8.18
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 8.17
Gene expression profile of human iPSC-derived nephron progenitor cells 7.95
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.78
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.78
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 7.76
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 7.75
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.73
MYCL and EP400 are required for Max and MCPyV mediated gene activation 7.64
Effect of PRDM11 depletion in U2932 cells 7.62
Human cell line and subcutaneous tumor 7.6
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 7.5
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 7.48
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 7.43
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 7.39
Global Mapping of Human RNA-RNA Interactions 7.34
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 7.33
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 7.29
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.23
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.22
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 7.21
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.21
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.17
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.11
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.09
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 7.06
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 7.04
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 7.03
The cohesin complex prevents Myc-induced replication stress 7.01
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 6.98
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 6.91
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.84
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 6.84
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 6.8
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.76
Functional role of SLIT2 and ROBO1 in trophoblasts 6.74
Regionally specified human pluripotent stem cell-derived astrocytes 6.64
Cajal bodies are linked to genome conformation 6.49
Cajal bodies are linked to genome conformation [RNA-Seq] 6.49
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 6.44
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 6.44
p53 activity results in DNA replication fork processivity 6.26
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.14
HNRNPM-regulated splicing dependencies in prostate cancer 6.13
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 6.13
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 6.07
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.94
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.91
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 5.89
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.88
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.88
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 5.86
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 5.76
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.73
KSDM1b Role in Ewing Sarcoma 5.72
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.61
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 5.55
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.53
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 5.52
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 5.47
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.44
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 5.4
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 5.4
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 5.38
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.38
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 5.36
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 5.35
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.33
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.33
Expression profiles of the four human major ectodermal lineages 5.31
Transcriptome analysis of H9 hESC derived cerebral organoids 5.31
Zika virus infection reprograms global transcription of host cells to allow sustained infection 5.3
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 5.28
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.26
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.26
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.26
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.23
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.23
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 5.22
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 5.16
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 5.16
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 5.07
Lysine benzoylation is a novel histone mark 5.06
Lysine benzoylation is a novel histone mark [RNA-seq] 5.06
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.06
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.06
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 5.02
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 5.02
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 5.01
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 5.01
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 5.01
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 4.95
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 4.95
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.87
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.85
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 4.84
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 4.83
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.83
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.83
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.81
Real-time observation of light-controlled transcription in living cells 4.81
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.78
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.78
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 4.74
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 4.73
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 4.68
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.66
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.66
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 4.6
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.6
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.58
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.57
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 4.54
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 4.54
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 4.52
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 4.48
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 4.48
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 4.48
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.45
RNA-seq of YB5 cells treated with Proscillaridin A 4.44
Gene expression changes after LOC550643 silencing 4.43
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 4.41
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.39
hTERT promotes cell adhesion and migration independent of telomerase activity 4.39
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 4.37
The role of FAM46C in myeloma cells [sequencing] 4.35
The role of FAM46C in myeloma cells 4.35
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 4.33
Mapping interactions for the TNIP2 hub protein 4.32
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 4.31
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.28
Systematic discovery of endogenous human ribonucleoprotein complexes 4.27
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 4.26
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.23
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 4.22
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 4.18
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.18
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.18
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 4.18
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 4.18
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 4.18
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.16
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.14
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 4.14
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 4.14
LNCaP treated with iBET 4.13
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.12
Transcriptional profiles of normal human mature B cells 4.11
Gene expression in GBM with Cav3.2 inhibition 4.09
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 4.05
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.05
ARID1A regulates condensin II distribution and chromosomal partition 4.03
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 4.03
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.01
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.01
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 4.01
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 4.0
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 3.98
SLIGRL-induced gene expression changes in NHEK cells 3.97
Inhibition of TNBC metastasis by Gpx1 3.96
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 3.92
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.91
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.87
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.87
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 3.81
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.76
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 3.76
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.76
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.76
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 3.74
Gene induction by the USP6 oncogene in response to interferon 3.72
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.68
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 3.66
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 3.66
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.63
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 3.62
RNA-seq analysis to identify the genes regulated by p53-SET interplay 3.62
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.62
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.56
Expression and functions of long noncoding RNAs during human T helper cell differentiation 3.54
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.54
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.52
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 3.52
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.51
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 3.5
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.49
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 3.49
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 3.49
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 3.48
IMP3 regulated gene expression in breast cancer cells 3.47
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.44
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 3.42
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 3.41
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 3.41
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.39
U1 snRNP telescripting regulates size-function stratified human genome 3.37
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 3.34
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 3.34
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 3.33
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 3.33
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.33
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.3
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.3
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.27
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 3.27
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.26
Profiling of escape kinetics of viruses subjected to RNAi 3.22
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.21
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 3.16
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.16
mRNA recovered upon RNF219 IP. [RNA-IP] 3.16
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 3.14
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.12
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 3.1
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.1
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.1
Comparison of microRNA Profiling Platforms (HTS) 3.01
Comparison of microRNA Profiling Platforms 3.01
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.0
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.0
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 3.0
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 3.0
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.99
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.99
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.98
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.98
Functional role of CPPED1 in trophoblasts. 2.97
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 2.96
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.94
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.94
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.93
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.92
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.92
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 2.91
Induction of Cardiomyocyte Proliferation [pz-822_human] 2.9
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 2.9
Transcriptome analysis of BAP1 knockout and restoration 2.89
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 2.89
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.88
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 2.86
RNA expression analysis upon JMJD1C depletion 2.83
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.83
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.83
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 2.83
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 2.82
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 2.77
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 2.77
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.76
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.75
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.74
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.71
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.71
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.7
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.67
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.64
RNA seq comparison between scrambled and shGRP78 cells 2.63
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.62
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.62
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 2.61
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.58
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.58
Functional significance of the HIV-1 Tat signature amino acid residues 2.54
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.51
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.47
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.46
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 2.46
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.43
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.43
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.41
Ribosome profiling upon inhibition of eIF4A 2.41
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 2.39
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 2.35
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.31
RNA splicing alteration on glioblastoma and normal neural stem cells 2.31
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.31
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.29
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.28
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.26
Controlling for gene expression changes in transcription factor protein networks. 2.25
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.24
Global transcriptome analysis of HAP1 cells 2.24
Activity-dependent transcriptional changes in human neurons 2.23
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.2
PRDM1 inhibits proliferation of human colon cancer organoids 2.14
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.13
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.12
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.09
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.06
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 2.04
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.02
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.97
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.96
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.93
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.88
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.86
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.86
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.86
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.85
RNA-seq analysis of control and Myc-induced U2OS cells 1.8
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.78
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.76
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.76
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.76
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.75
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 1.73
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 1.72
4sU-seq of HFF exposed to salt and heat stress 1.71
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.68
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.67
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.66
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.66
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.65
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.63
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 1.63
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.63
Gene expression analysis upon mtDNA depletion 1.63
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 1.63
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.62
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.62
Gene expression profile in breast cancer cells 1.62
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.6
Leucegene: ALL sequencing 1.59
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.57
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.55
The cohesin release factor WAPL restricts chromatin loop extension. 1.55
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.54
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.54
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.54
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.52
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.51
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.48
High-resolution comparative analysis of great ape genomes 1.45
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.39
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.38
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.37
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.36
Identification of a LIF-responsive replication-competent human β cell 1.35
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.35
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.35
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.33
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.33
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.32
The contribution of Alu exons to the human proteome 1.31
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 1.3
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.27
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.25
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.25
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.19
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.19
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.19
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.16
O-glcnAc reprograms cellular energetics 1.16
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.15
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.15
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.13
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.11
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.09
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.09
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.07
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.05
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.03
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.03
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.03
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.91
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.9
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.9
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.89
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.88
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.87
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.86
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.86
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.86
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.85
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.84
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.84
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 0.78
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.78
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.78
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.77
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.76
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.75
CHCHD2 gene KO effect in iPSC drived motor neurons 0.74
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.72
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.68
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.66
siRNA-mediated knockdown 0.63
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.62
An optimization system for isolating and sequencing of single human colon cancer cells 0.61
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.6
RNA-seq of cells with TET1 knockout 0.6
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.59
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.57
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.57
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.55
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.54
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.54
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.53
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.52
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.51
Modeling Human Cancer-induced Cachexia (Human) 0.49
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.48
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.47
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.44
Differential responses of human fetal brain neural stem cells to Zika virus infection 0.43
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 0.43
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.41
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.4
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.37
RNA-seq of cancer cell lines treated with T-025 0.36
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.36
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.36
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.36
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.36
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.36
Analyses of T-ALL (COG study) 0.35
RNA sequencing of T-ALL (COG study) 0.35
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.33
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.32
Oncogenic roles of ARID5B in T-ALL 0.32
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.32
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.29
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.28
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.27
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.25
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.25
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.24
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.23
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.19
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.18
Modulation of nonsense-mediated decay by rapamycin 0.15
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.15
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.15
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.15
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.14
Transcriptome-wide response to synthetic chromatin protein PcTF 0.14
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.14
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.14
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.13
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.13
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.13
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.12
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.11
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.11
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.1
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.09
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.07
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.07
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.04
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.04
Gene expression changes due to PARP knockdown in human cells 0.04
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation